Growth Metrics

Moderna (MRNA) Change in Acquisitions & Divestments: 2018-2025

Historic Change in Acquisitions & Divestments for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to $1.2 billion.

  • Moderna's Change in Acquisitions & Divestments rose 8.81% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 billion, marking a year-over-year increase of 0.65%. This contributed to the annual value of $5.6 billion for FY2024, which is 0.23% down from last year.
  • According to the latest figures from Q3 2025, Moderna's Change in Acquisitions & Divestments is $1.2 billion, which was down 18.85% from $1.5 billion recorded in Q2 2025.
  • Moderna's Change in Acquisitions & Divestments' 5-year high stood at $2.0 billion during Q2 2024, with a 5-year trough of $277.0 million in Q3 2021.
  • Over the past 3 years, Moderna's median Change in Acquisitions & Divestments value was $1.4 billion (recorded in 2023), while the average stood at $1.4 billion.
  • In the last 5 years, Moderna's Change in Acquisitions & Divestments surged by 451.21% in 2021 and then tumbled by 43.85% in 2022.
  • Moderna's Change in Acquisitions & Divestments (Quarterly) stood at $1.1 billion in 2021, then crashed by 43.85% to $630.0 million in 2022, then skyrocketed by 37.14% to $864.0 million in 2023, then rose by 5.79% to $914.0 million in 2024, then climbed by 8.81% to $1.2 billion in 2025.
  • Its Change in Acquisitions & Divestments stands at $1.2 billion for Q3 2025, versus $1.5 billion for Q2 2025 and $1.9 billion for Q1 2025.